Cetera Investment Advisers’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.1M Sell
57,323
-23,655
-29% -$1.32M ﹤0.01% 1872
2025
Q4
$4.54M Buy
80,978
+11,683
+17% +$605K 0.01% 1525
2025
Q3
$3.32M Buy
69,295
+62,706
+952% +$2.8M ﹤0.01% 1739
2025
Q2
$267K Sell
6,589
-40
-0.6% -$1.61K ﹤0.01% 3493
2025
Q1
$290K Sell
6,629
-1,000
-13% -$44.1K ﹤0.01% 3291
2024
Q4
$328K Sell
7,629
-718
-9% -$32.6K ﹤0.01% 3038
2024
Q3
$370K Sell
8,347
-419
-5% -$17.9K ﹤0.01% 2890
2024
Q2
$349K Sell
8,766
-858
-9% -$34.8K ﹤0.01% 2905
2024
Q1
$415K Buy
+9,624
New +$415K ﹤0.01% 2762
2020
Q2
Sell
-11,100
Closed -$400K 634
2020
Q1
$400K Buy
+11,100
New +$473K 0.05% 341

Other funds holding XPH